Prof. Liu Zhibo’s team from Peking University (PKU)’s College of Chemistry and Molecular Engineering, along with collaborators, recently published a paper titled “Covalent targeted radioligands potentiate radionuclide therapy” in Nature. This marks the journal’s first publication on radionuclide therapy since 1977. (Radionuclides are radioactive forms of elements.)
Medical Xpress – latest medical and health news stories
